Legislation

Trend Analysis: Legitimizing Pseudoscience
Public Policy Trend Analysis: Legitimizing Pseudoscience

A parent, desperate for reliable guidance on autism treatments for their child, turns to what should be the most trustworthy source in the nation—the Food and Drug Administration's website—only to find that a page once dedicated to warning against fraudulent and dangerous "cures" has

NY's Paid Leave Law Fails Workers at $170 a Week
Public Policy NY's Paid Leave Law Fails Workers at $170 a Week

For a New Yorker diagnosed with a serious illness, the path to recovery is often overshadowed by the looming threat of financial ruin, a reality cemented by an outdated state law that has failed to keep pace with the modern cost of living. This is not a hypothetical scenario but the stark reality

Can Wyoming Turn a Grant Into a Forever Fund?
Business Can Wyoming Turn a Grant Into a Forever Fund?

In the vast, sparsely populated landscapes of Wyoming, state officials have unveiled a financial strategy so audacious it borders on alchemy: a plan to transform a temporary federal grant into a permanent, self-sustaining lifeline for its struggling rural healthcare system. The proposal, centered

Oregon Bill on Safe Spaces Faces Legal Hurdles
Public Policy Oregon Bill on Safe Spaces Faces Legal Hurdles

A groundbreaking legislative proposal designed to shield Oregon’s medical facilities from federal immigration enforcement has ignited a fierce debate, placing the fundamental right to health care on a collision course with the authority of the U.S. government. The bill, a collaborative effort b

Swiss Model Merges Cannabis With Modern Medicine
Public Policy Swiss Model Merges Cannabis With Modern Medicine

In a global healthcare landscape often characterized by a polarized debate between rapid deregulation and staunch prohibition, Switzerland has quietly cultivated a pragmatic third way for integrating novel therapeutics into its medical establishment. This approach, centered on medical cannabis,

Cigna Cuts 2,000 Jobs, Settles FTC Insulin Suit
Business Cigna Cuts 2,000 Jobs, Settles FTC Insulin Suit

In a move reflecting the immense pressures of regulatory scrutiny and corporate realignment within the American healthcare industry, global health giant Cigna has initiated a significant workforce reduction while simultaneously resolving a high-profile federal lawsuit over its prescription drug

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later